BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 6251109)

  • 1. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.
    Gershengorn MC; Arevalo CO; Geras E; Rebecchi MJ
    J Clin Invest; 1980 Jun; 65(6):1294-300. PubMed ID: 6251109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M; Yamaji T
    J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
    Reuss WA; Saeger W; Lüdecke DK
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH response to TRH and somatostatin in Nelson's syndrome.
    Ambrosi B; Bochicchio D; Sartorio A; Rondena M; Riva E
    Horm Metab Res; 1982 Mar; 14(3):164. PubMed ID: 6121749
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
    Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.
    Pimentel-Filho FR; Cukiert A; Miyashita F; Huayllas MK; Knoepfelmacher M; Salgado LR; Liberman B
    J Endocrinol Invest; 2001 Feb; 24(2):83-7. PubMed ID: 11263476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture.
    Gershengorn MC
    J Clin Invest; 1978 Nov; 62(5):937-43. PubMed ID: 213447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumors containing cholecystokinin.
    Rehfeld JF; Lindholm J; Andersen BN; Bardram L; Cantor P; Fenger M; Lüdecke DK
    N Engl J Med; 1987 May; 316(20):1244-7. PubMed ID: 3033502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.